Naringenin inhibits TNF-α induced VSMC proliferation and migration via induction of HO-1

Food and Chemical Toxicology

Volumn 50, Issue 9, 2012, Pages 3025-3031

  Chen, Siyu ^a   Ding, Yan ^a   Tao, Weiwei ^a   Zhang, Wenxiang ^a   Liang, Tingming ^a   Liu, Chang ^a  

^a NANJING NORMAL UNIVERSITY   (China)

Author keywords

Heme oxygenase 1; Migration; Naringenin; Proliferation; Vascular smooth muscle cells

Indexed keywords

HEME OXYGENASE 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NARINGENIN; PROTEIN KINASE B; PROTOPORPHYRIN ZINC; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; MALE; MIGRATION INHIBITION; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DNA PRIMERS; ENZYME INDUCTION; FLAVANONES; HEME OXYGENASE-1; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

CITRUS; RATTUS;

EID: 84864030693     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.06.006     Document Type: Article

References (38)

1. Adhikari N., Charles N., Lehmann U., Hall J.L. Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury. Curr. Atheroscler. Rep. 2006, 8:252-260.
2. Cayci C., Wahlquist T.C., Seckin S.I., Ozcan V., Tekinay A.B., Martens T.P., Oz M.C., Ascherman J.A. Naringenin inhibits neointimal hyperplasia following arterial reconstruction with interpositional vein graft. Ann. Plast. Surg. 2010, 64:105-113.
3. Chandrasekar B., Bysani S., Mummidi S. CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J. Biol. Chem. 2004, 279:3188-3196.
4. Chanet A., Milenkovic D., Deval C., Potier M., Constans J., Mazur A., Bennetau-Pelissero C., Morand C., Berard A.M. Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in mice. J. Nutr. Biochem. 2011.
5. Duckers H.J., Boehm M., True A.L., Yet S.F., San H., Park J.L., Clinton Webb R., Lee M.E., Nabel G.J., Nabel E.G. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat. Med. 2001, 7:693-698.
6. Dugourd C., Gervais M., Corvol P., Monnot C. Akt is a major downstream target of PI3-kinase involved in angiotensin II-induced proliferation. Hypertension 2003, 41:882-890.
7. Gordon D., Mohai L.G., Schwartz S.M. Induction of polyploidy in cultures of neonatal rat aortic smooth muscle cells. Circ. Res. 1986, 59:633-644.
8. Grotendorst G.R., Seppa H.E., Kleinman H.K., Martin G.R. Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 1981, 78:3669-3672.
9. Han X., Ren D., Fan P., Shen T., Lou H. Protective effects of naringenin-7-O-glucoside on doxorubicin-induced apoptosis in H9C2 cells. Eur. J. Pharmacol. 2008, 581:47-53.
10. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352:1685-1695.
11. Kapturczak M.H., Wasserfall C., Brusko T., Campbell-Thompson M., Ellis T.M., Atkinson M.A., Agarwal A. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am. J. Pathol. 2004, 165:1045-1053.
12. Kim J.E., Kang Y.J., Lee K.Y., Choi H.C. Isoproterenol inhibits angiotensin II-stimulated proliferation and reactive oxygen species production in vascular smooth muscle cells through heme oxygenase-1. Biol. Pharm. Bull. 2009, 32:1047-1052.
13. Lee E.J., Kim D.I., Kim W.J., Moon S.K. Naringin inhibits matrix metalloproteinase-9 expression and AKT phosphorylation in tumor necrosis factor-alpha-induced vascular smooth muscle cells. Mol. Nutr. Food Res. 2009, 53:1582-1591.
14. Libby P., Ridker P.M., Hansson G.K. Inflammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol. 2009, 54:2129-2138.
15. Lin H.Y., Shen S.C., Chen Y.C. Anti-inflammatory effect of heme oxygenase 1: glycosylation and nitric oxide inhibition in macrophages. J. Cell. Physiol. 2005, 202:579-590.
16. Majack R.A., Clowes A.W. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J. Cell. Physiol. 1984, 118:253-256.
17. Marshall N.J., Goodwin C.J., Holt S.J. A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regul. 1995, 5:69-84.
18. McCoubrey W.K., Huang T.J., Maines M.D. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur. J. Biochem. 1997, 247:725-732.
19. Minamino T., Christou H., Hsieh C.M., Liu Y., Dhawan V., Abraham N.G., Perrella M.A., Mitsialis S.A., Kourembanas S. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc. Natl. Acad. Sci. USA 2001, 98:8798-8803.
20. Moe S.M., Chen N.X. Pathophysiology of vascular calcification in chronic kidney disease. Circ. Res. 2004, 95:560-567.
21. Mulvihill E.E., Allister E.M., Sutherland B.G., Telford D.E., Sawyez C.G., Edwards J.Y., Markle J.M., Hegele R.A., Huff M.W. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes 2009, 58:2198-2210.
22. Newby A.C., Zaltsman A.B. Molecular mechanisms in intimal hyperplasia. J. Pathol. 2000, 190:300-309.
23. Nhiem N.X., Kiem P.V., Minh C.V., Lee J.J., Ku J.H., Myung C.S., Kim Y.H. A potential inhibitor of rat aortic vascular smooth muscle cell proliferation from the pollen of Typha angustata. Arch. Pharm. Res. 2010, 33:1937-1942.
24. Otterbein L.E., Zuckerbraun B.S., Haga M., Liu F., Song R., Usheva A., Stachulak C., Bodyak N., Smith R.N., Csizmadia E., Tyagi S., Akamatsu Y., Flavell R.J., Billiar T.R., Tzeng E., Bach F.H., Choi A.M., Soares M.P. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat. Med. 2003, 9:183-190.
25. Patel R.P., Moellering D., Murphy-Ullrich J., Jo H., Beckman J.S., Darley-Usmar V.M. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free. Radic. Biol. Med. 2000, 28:1780-1794.
26. Poss K.D., Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. USA 1997, 94:10925-10930.
27. Rogers P.A., Abberton K.M. Endometrial arteriogenesis: vascular smooth muscle cell proliferation and differentiation during the menstrual cycle and changes associated with endometrial bleeding disorders. Microsc. Res. Tech. 2003, 60:412-419.
28. Saponara S., Testai L., Iozzi D., Martinotti E., Martelli A., Chericoni S., Sgaragli G., Fusi F., Calderone V. (+/-)-Naringenin as large conductance Ca(2+)-activated K+ (BKCa) channel opener in vascular smooth muscle cells. Br. J. Pharmacol. 2006, 149:1013-1021.
29. Sprague A.H., Khalil R.A. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem. Pharmacol. 2009, 78:539-552.
30. Tenhunen R., Marver H.S., Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. USA 1968, 61:748-755.
31. Terao J., Kawai Y., Murota K. Vegetable flavonoids and cardiovascular disease. Asia Pac. J. Clin. Nutr. 2008, 17(Suppl 1):291-293.
32. Touyz R.M. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp. Physiol. 2005, 90:449-455.
33. Tulis D.A. Methods for identifying cardiovascular agents: a review. Recent Pat. Cardiovasc. Drug. Discov. 2006, 1:47-56.
34. Vaziri N.D. Causal link between oxidative stress, inflammation, and hypertension. Iran J. Kidney. Dis. 2008, 2:1-10.
35. Wagner C.T., Durante W., Christodoulides N., Hellums J.D., Schafer A.I. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J. Clin. Invest. 1997, 100:589-596.
36. Yachie A., Niida Y., Wada T., Igarashi N., Kaneda H., Toma T., Ohta K., Kasahara Y., Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 1999, 103:129-135.
37. Yoshinaga T., Sassa S., Kappas A. Purification and properties of bovine spleen heme oxygenase. Amino acid composition and sites of action of inhibitors of heme oxidation. J. Biol. Chem. 1982, 257:7778-7785.
38. Zhang M., Zhang B.H., Chen L., An W. Overexpression of heme oxygenase-1 protects smooth muscle cells against oxidative injury and inhibits cell proliferation. Cell Res. 2002, 12:123-132.